Broader metabolic models
Recent mouse research expanded beyond body composition to examine glucose control, insulin response, liver fat, inflammation, and tissue distribution.
P—26 • Small-molecule NNMT profile
5-Amino-1MQ(Also known as 5-amino-1-methylquinolinium)
An educational overview of a small-molecule NNMT inhibitor being explored across cellular energy balance, fat-cell biology, glucose regulation, and liver metabolism.
Name
5-Amino-1MQ
5-amino-1-methylquinolinium; often abbreviated 5A1MQ
- Scientific classification
- Membrane-permeable methylquinolinium small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT)
- Library family
- Metabolic
- Regulatory status
- Not FDA approved; no established human use
Compound overview
A compact small molecule helping researchers explore NNMT as a metabolic control point.
5-Amino-1MQ is a synthetic small molecule—not a peptide—designed to inhibit nicotinamide N-methyltransferase, commonly called NNMT. This enzyme helps determine how cells use nicotinamide and methyl donors, connecting it to several pathways involved in cellular energy and metabolic balance.
Foundational laboratory work showed that 5-Amino-1MQ can enter cells and reduce NNMT activity. In fat-cell and mouse studies, researchers then observed encouraging changes in body composition and metabolic measurements, making the compound a useful tool for investigating how NNMT influences energy storage and use.
The research has continued to broaden. A 2024 mouse study examined glucose handling, insulin sensitivity, liver fat, inflammation, pharmacokinetics, and distribution into metabolically active tissues. The results strengthened interest in NNMT inhibition as a research strategy for studying obesity-related metabolic dysfunction and liver biology.
The next important step is translation. Controlled human trials have not established safety, effectiveness, dosing, or long-term outcomes, so the current evidence should be understood as promising preclinical research rather than proof of a human benefit.
Liver and fat-cell biology
Researchers are using NNMT inhibition to explore how fat cells and the liver respond to metabolic stress and changes in cellular fuel handling.
The human-research gap
Carefully controlled human studies are still needed to determine safety, pharmacology, and whether laboratory findings translate to people.
Mechanism under study
NNMT inhibition and cellular methyl-donor metabolism
Research examines how NNMT inhibition changes nicotinamide methylation and related metabolic pools in cells and animal models.
Enzyme inhibition
5-Amino-1MQ inhibits NNMT, reducing conversion of nicotinamide to 1-methylnicotinamide in experimental systems.
Nicotinamide metabolism
Preclinical work measures changes in NAD+ biology following NNMT inhibition.
Methyl-donor balance
Studies also examine S-adenosylmethionine and connected metabolic pathways in adipose and liver models.
Cellular and mouse-model findings cannot establish human benefit, safety, dose, or long-term effects.
Current research areas
Questions under investigation
- How NNMT affects cellular energy balance
- How fat cells store and use energy
- How the liver responds to metabolic stress
- NAD+ and methyl-donor balance
- Safety and whether animal findings translate to people
Evidence summary
Promising preclinical metabolic research
- Cell research: Early studies showed that 5-Amino-1MQ can enter cells, inhibit NNMT, and change metabolic markers in cultured fat cells.
- Body-composition models: Mouse studies reported encouraging changes in fat mass and related metabolic measurements.
- Glucose and insulin research: More recent mouse work examined glucose tolerance, insulin sensitivity, and high insulin levels associated with metabolic dysfunction.
- Liver research: Preclinical findings included lower liver fat and reduced signs of liver inflammation in the studied mouse model.
- Research opportunity: The growing evidence provides a foundation for carefully designed safety, pharmacology, and eventual human research.
These findings support continued investigation, but the evidence is still based on cells and animal models and does not establish weight-loss, metabolic, liver, or other health benefits in people.
Educational notice
Education, not usage guidance.
This profile is provided for scientific education only. It is not medical advice, weight-loss guidance, dosing information, or instructions for 5-Amino-1MQ use. 5-Amino-1MQ is a laboratory research compound, not an approved medicine, and controlled human safety and efficacy have not been established.
Key scientific referencesComing soon
A curated primary-source reference list will be added during the next educational expansion.